Pb1901 ibrutinib, single agent btk inhibitor, for relapsed/refractory (r/r) chronic lymphocytic leukemia: a real-world experience from rete ematologica pugliese (rep).P.R. Scalzulli,A. Guarini,G. Loseto,G. Specchia, A.M. Giordano,D. Pastore, G. Quintana,A. Maggi, P. Mazza,N. Di Renzo,M.R. De Paolis,G. Tarantini, G. De Santis, V. Pavone, A. Greco,M.R. Valvano, G. Rossi,N. CascavillaHemaSphere（2019）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
